Sebastian Turet examines Texas's new gender-affirming care ban, analyzing potential constitutional challenges to its enforcement and exploring possible constitutional rights that could be invoked to preempt the legislation.
Hiba Loya examines the overmedication of foster youth in Texas, analyzing legal and regulatory challenges, the impact of M.D. v. Abbott, and proposing reforms to better protect vulnerable children.
%22%20%2F%3E%3C%2Fsvg%3E)
Articles Uncertainty persists over ERISA preemption as states try to regulate pharmacy benefits managers in order to protect rural independent pharmacies and ensure access to pharmacy services for their communities.
%22%20%2F%3E%3C%2Fsvg%3E)
Articles Professors Mahsa Shabani & Vasiliki Rahimzadeh examine the importance of integrating fairness assessments into the regulatory approval process for AI and machine learning enabled medical devices.
%22%20%2F%3E%3C%2Fsvg%3E)
Articles Professors Amy B. Cyphert & Valarie K. Blake critically examine the burgeoning intersection of generative AI and synthetic data within the healthcare sector.
Professor E.H. Morreim explores how errors in electronic medical records (EMRs) critically undermine the potential of AI.
Professor Stacey A. Tovino provides a thorough examination of the intersection between HIPAA regulations and the rapidly evolving role of AI in healthcare.
%22%20%2F%3E%3C%2Fsvg%3E)
Articles Professor Seth J. Chandler introduces the 24(1) Symposium Issue on AI in Healthcare and expands on thoughtful approaches to privacy, data integrity, and fairness.
%22%20%2F%3E%3C%2Fsvg%3E)
Health Law Perspectives Cory Ehlenbach explores how the Dobbs decision placed physicians in states with restrictive abortion laws at legal risk when assessing medical emergencies due to narrowly defined statutory terms.
%22%20%2F%3E%3C%2Fsvg%3E)
Health Law Perspectives Nick Boden explores how ERISA's preemption clause complicates state healthcare reform efforts despite insights from recent cases.
%22%20%2F%3E%3C%2Fsvg%3E)
Articles Claire McGovern identifies the potential harms posed by posthumous conception technology, exploring how regulation can be used to minimize these harms and further protect the interests of stakeholders.